ConductScience.org, home

Paper76166

Prevention by bedtime cimetidine of duodenal-ulcer relapse.

Blackwood WS and 2 others. Lancet, 1978. Cited by 91 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Prevention by bedtime cimetidine of duodenal-ulcer relapse. Papers, record 76166. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/76166

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prevention by bedtime cimetidine of duodenal-ulcer relapse.
PubMed
Journal
Lancet
PubMed
Year
1978
PubMed
Publication types
Case Reports, Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
91
iCite
Relative citation ratio, by iCite
4.88
iCite
Revised in PubMed
2019-06-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Blackwood WSW S
2Maudgal DPD P
3Northfield TCT C

Source PubMed

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CimetidineMajor topic
Duodenal UlcerMajor topic
GuanidinesMajor topic
Adult
Child
Clinical Trials as Topic
Double-Blind Method
Drug Evaluation
Female
Follow-Up Studies
Humans
In Vitro Techniques
Infant
Male
Middle Aged
Placebos
Recurrence
Time Factors

Source PubMed

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 91 citations.

PMIDTitleJournalYearIn PapersSource
7,410,042Cimetidine and duodenal ulcer: a study of initial and low dosage maintenance treatment in Ireland.Ir J Med Sci1980https://conductscience.org/library/papers/7410042PubMed
7,259,925Cimetidine-a clinical and pharmacokinetic study.Br J Clin Pharmacol1981https://conductscience.org/library/papers/7259925PubMed
7,220,403Effect of treatment with cimetidine for one year on gastrin cell and parietal cell function and sensitivity to cimetidine in patients with duodenal or gastric ulcers.Postgrad Med J1980https://conductscience.org/library/papers/7220403PubMed
7,205,728Problems in the medical treatment of peptic ulcers.J R Coll Physicians Lond1980https://conductscience.org/library/papers/7205728PubMed
7,040,178Bedtime cimetidine maintenance treatment: optimum dose and effect on subsequent natural history of duodenal ulcer.Gut1982https://conductscience.org/library/papers/7040178PubMed
7,000,474Cimetidine vs placebo in duodenal ulcer therapy. Six-week controlled double-blind investigation without any antacid therapy.Dig Dis Sci1980https://conductscience.org/library/papers/7000474PubMed
6,986,242Relapse rate of duodenal ulcer after cessation of long-term cimetidine treatment: a double-blind controlled study.Dig Dis Sci1980https://conductscience.org/library/papers/6986242PubMed
6,786,895Effect of fifteen months of double-blind treatment with cimetidine and placebo on peptic ulcer recurrence.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/6786895PubMed
6,311,692Single nocturnal dose of an H2 receptor antagonist for the treatment of duodenal ulcer.Gut1983https://conductscience.org/library/papers/6311692PubMed
6,141,898Effect of a new potent H2-receptor antagonist on meal-stimulated gastric acid secretion and serum gastrin concentration in duodenal ulcer patients.Dig Dis Sci1984https://conductscience.org/library/papers/6141898PubMed
3,792,425Effect of 11R, 16, 16-trimethyl prostaglandin E2 on meal-stimulated gastric acid secretion in duodenal ulcer subjects.Eur J Clin Pharmacol1986https://conductscience.org/library/papers/3792425PubMed
3,080,282Effect of misoprostol, an antiulcer prostaglandin, on serum gastrin in patients with duodenal ulcer.Dig Dis Sci1986https://conductscience.org/library/papers/3080282PubMed
678,819Maintenance treatment of duodenal ulcer with cimetidine.Br Med J1978https://conductscience.org/library/papers/678819PubMed
532,144Medical staff conference: cimetidine.West J Med1979https://conductscience.org/library/papers/532144PubMed
482,183Cimetidine in the prevention of gastric ulcer relapse.Postgrad Med J1979https://conductscience.org/library/papers/482183PubMed
421,004Cimetidine and duodenal ulcer.Br Med J1979https://conductscience.org/library/papers/421004PubMed
382,159Review of general surgery 1978.Postgrad Med J1979https://conductscience.org/library/papers/382159PubMed
381,127Controlled trial of maintenance cimetidine treatment in healed duodenal ulcer: short and long-term effects.Gut1979https://conductscience.org/library/papers/381127PubMed
378,626Long-term cimetidine in duodenal ulcer disease.Dig Dis Sci1979https://conductscience.org/library/papers/378626PubMed
342,231Cimetidine: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.Drugs1978https://conductscience.org/library/papers/342231PubMed

See all 21 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/76166

GET https://conductscience.org/api/papers/v1/76166/cited_by?page=2